1834 Investment Advisors’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

1834 Investment Advisors’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-243	Closed	-$4K	–	486
2020 Q2	$4K	Hold	243	–	–	﹤0.01%	402
2020 Q1	$2K	Hold	243	–	–	﹤0.01%	387
2019 Q4	$6K	Hold	243	–	–	﹤0.01%	417
2019 Q3	$7K	Hold	243	–	–	﹤0.01%	410
2019 Q2	$7K	Hold	243	–	–	﹤0.01%	391
2019 Q1	$8K	Hold	243	–	–	﹤0.01%	364
2018 Q4	$5K	Hold	243	–	–	﹤0.01%	380
2018 Q3	$6K	Hold	243	–	–	﹤0.01%	378
2018 Q2	$9K	Hold	243	–	–	﹤0.01%	377
2018 Q1	$8K	Hold	243	–	–	﹤0.01%	400
2017 Q4	$12K	Buy	+243	New	+$12.3K	﹤0.01%	402

1834 Investment Advisors's PTLA Position: Q3 2020 in Review

1834 Investment Advisors sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 243 shares — an estimated $4K sold.

1834 Investment Advisors first reported a position in PTLA in Q4 2017 and held it in 11 quarters. The position peaked at $12K in Q4 2017. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

1834 Investment Advisors reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
1834 Investment Advisors sold 243 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $4K.
1834 Investment Advisors first reported a position in Portola Pharmaceuticals, Inc. in Q4 2017 and held it in 11 quarters.
1834 Investment Advisors's Portola Pharmaceuticals, Inc. position peaked at $12K in Q4 2017.
0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on 1834 Investment Advisors's 13F filing for Q3 2020, filed 16 Nov 2020.